---
layout: post
title: "Immix Biopharma(IMMX.O)盘前飙升逾80%"
date: 2022-01-03 21:09:55 +0800
categories: hafuzixun
tags: 哈富资讯新闻
---
<p style="display:none;height:1px;overflow:hidden;"> </p><!-- EM_StockImg_Start --><p style="text-align:center;"><img src="https://webquoteklinepic.eastmoney.com/GetPic.aspx?nid=105.IMMX&imageType=k&token=28dfeb41d35cc81d84b4664d7c23c49f&at=1" alt="K图 IMMX_0" data-code="K IMMX|105|7" data-code2="K IMMX|105|1|" style="border:#d1d1d1 1px solid;" width="578" height="276" border="0" /></p><!-- EM_StockImg_End --><p>Immix Biopharma(IMMX.O)盘前飙升逾80%，美国食品药品监督管理局批准其药物IMX-110用于治疗危及生命的儿童癌症。 <br /></p><p class="em_media">（文章来源：哈富资讯）</p>

<http://finews.zning.xyz/html_News/NewsShare.html?infoCode=NW202201032234437896>

[返回哈富资讯新闻](//finews.withounder.com/category/hafuzixun.html)｜[返回首页](//finews.withounder.com/)